UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
MDNAF holding history
Medicenna Therapeutics Corp. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDNAF overviewAll 13F holders of MDNAFFull Q2 2026 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q4 2021